Dendritic cell–based vaccines have been rapidly transferred from the laboratory to the clinic. As the full potential of these cells has not yet been entirely exploited, many strategies could improve the immunogenicity of these vaccines.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing
BMC Immunology Open Access 29 June 2023
-
Comparative study of clinical grade human tolerogenic dendritic cells
Journal of Translational Medicine Open Access 09 June 2011
-
Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer
Journal of Translational Medicine Open Access 22 July 2008
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
K.R.
References
Banchereau, J. & Steinman, R.M. Nature 392, 245–252 (1998).
Hsu, F.J. et al. Nat. Med. 2, 52–58 (1996).
Schuler, G., Schuler-Thurner, B. & Steinman, R.M. Curr. Opin. Immunol. 15, 138–147 (2003).
Thurner, B. et al. J. Exp. Med. 190, 1669–1678 (1999).
Banchereau, J. et al. Cancer Res. 61, 6451–6458 (2001).
Dhodapkar, M.V. et al. J. Clin. Invest. 104, 173–180 (1999).
Coulie, P.G. et al. Proc. Natl. Acad. Sci. USA 98, 10290–10295 (2001).
Karanikas, V. et al. J. Immunol. 171, 4898–4904 (2003).
Speiser, D.E. et al. Eur. J. Immunol. 32, 731–741 (2002).
Smith, J.W. et al. J. Clin. Oncol. 21, 1562–1573 (2003).
Lee, P. et al. J. Clin. Oncol. 19, 3836–3847 (2001).
Schaed, S.G. et al. Clin. Cancer Res. 8, 967–972 (2002).
Pullarkat, V. et al. Clin. Cancer Res. 9, 1301–1312 (2003).
Lee, K.H. et al. J. Immunol. 163, 6292–300 (1999).
Salio, M. et al. Eur. J. Immunol. 33, 1052–1062 (2003).
Le Bon, A. et al. Nat. Immunol. 4, 1009–1015 (2003).
Lanzavecchia, A. & Sallusto, F. Nat. Rev. Immunol. 2, 982–987 (2002).
Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. & Steinman, R.M. J. Exp. Med. 198, 267–279 (2003).
Hermans, I.F. et al. J. Immunol. 171, 5140–5147 (2003).
Palmowski, M.J. et al. J. Immunol. 168, 4391–4398 (2002).
Schuler-Thurner, B. et al. J. Exp. Med. 195, 1279–12788 (2002).
Martin-Fontecha, A. et al. J. Exp. Med. 198, 615–621 (2003).
Itano, A.A. et al. Immunity 19, 47–57 (2003).
Acknowledgements
We thank G. Schuler, P. Coulie, P. Romero, C. Smith and M. Palmowski for comments on this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cerundolo, V., Hermans, I. & Salio, M. Dendritic cells: a journey from laboratory to clinic. Nat Immunol 5, 7–10 (2004). https://doi.org/10.1038/ni0104-7
Issue Date:
DOI: https://doi.org/10.1038/ni0104-7
This article is cited by
-
Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing
BMC Immunology (2023)
-
Autologous Dendritic Cell Based Adoptive Immunotherapy of Patients with Colorectal Cancer—A Phase I-II Study
Pathology & Oncology Research (2014)
-
Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer
International Journal of Colorectal Disease (2013)
-
From genes to drugs: targeted strategies for melanoma
Nature Reviews Cancer (2012)
-
In Vivo Imaging of Lymph Node Migration of MNP- and 111In-Labeled Dendritic Cells in a Transgenic Mouse Model of Breast Cancer (MMTV-Ras)
Molecular Imaging and Biology (2012)
